Transvaginal ultrasound‐guided direct thrombin injection for the treatment of intramyometrial pseudoaneurysm in a young female with uterine hemorrhage after failed uterine artery embolization

2020 ◽  
Author(s):  
Gurucharan S. Shetty ◽  
Gayathri D. Kamath ◽  
Pradeep Srinivasan
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Transvaginal Ultrasound ◽  
Young Female ◽  
Thrombin Injection ◽  
Uterine Hemorrhage ◽  
Ultrasound Guided ◽  
Artery Embolization

scholarly journals Contrast-enhanced ultrasound in uterine artery embolization treatment of cesarean scar pregnancy

2020 ◽  
Vol 48 (12) ◽  
pp. 030006052098021
Author(s):  
Dongmei Liu ◽  
Xiaoning Gu ◽  
Fang Liu ◽  
Fuwen Shi ◽  
Min Yang
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Transvaginal Ultrasound ◽  
Contrast Enhanced Ultrasound ◽  
Artery Embolization ◽  
Time Intensity Curve ◽  
Cesarean Scar Pregnancy ◽  
Cesarean Scar ◽  
Contrast Enhanced ◽  
Myometrial Thickness

Objective The current study aimed to investigate the application of contrast-enhanced ultrasound (CEUS) in diagnosis and treatment of cesarean scar pregnancy (CSP). Methods A retrospective study was performed in 35 patients with clinically suspected CSP who requested termination of pregnancy and underwent contrast-enhanced ultrasound (CEUS). The patients were classified into two groups on the basis of whether they received uterine artery embolization (UAE). The CEUS characteristics of the two groups were reviewed. Results CEUS features of CSP were early enhancement of the cesarean scar and continuous infusion of contrast agent between the gestational sac and cesarean scar. Myometrial thickness in the cesarean scar was thinner in the UAE group than in the non-UAE group by CEUS and transvaginal ultrasound. Myometrial thickness measured by CEUS was thinner than that measured by transvaginal ultrasound in both groups. The parameters of the time-intensity curve in the UAE group were characterized by a faster arrival time, shorter time to peak, higher peak intensity, and greater enhancement rate compared with the non-UAE group. Conclusions CEUS may be a novel supplementary method to diagnose and assess CSP, and to help evaluate whether UAE is required.

scholarly journals Uterine Artery Embolization in the Treatment of Postpartum Uterine Hemorrhage; Two Centers' Experience in 100 Patients

2020 ◽  
Author(s):  
Guerroum Hind ◽  
Kassimi Meriem ◽  
Habi Jihane ◽  
Chikhaoui Nabil ◽  
Mahi Mohamed ◽  
...  
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Uterine Hemorrhage ◽  
Artery Embolization

Uterine Artery Embolization in the Treatment of Postpartum Uterine Hemorrhage

2011 ◽  
Vol 22 (2) ◽  
pp. 169-176 ◽  
Author(s):  
Suvranu Ganguli ◽  
Michael S. Stecker ◽  
Deveraj Pyne ◽  
Richard A. Baum ◽  
Chieh-Min Fan
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Uterine Hemorrhage ◽  
Artery Embolization

scholarly journals Conservative treatment of cervical pregnancy with selective unilateral uterine artery embolization

Medicina ◽  
2007 ◽  
Vol 43 (11) ◽  
pp. 883 ◽  
Author(s):  
Rūta Nadišauskienė ◽  
Edvardas Vaicekavičius ◽  
Viktorija Tarasevičienė ◽  
Daiva Simanavičiūtė
Keyword(s):  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Transvaginal Ultrasound ◽  
Treatment Method ◽  
Cervical Canal ◽  
Artery Embolization ◽  
Sonographic Examination ◽  
Crown Rump Length ◽  
Cervical Pregnancy ◽  
Artery Flow

Background. Cervical pregnancy is a rare form of ectopic pregnancy, and the most effective method of its treatment is still under investigation. We would like to call attention to selective uterine artery embolization as an effective modern treatment method. Case. A patient with suspected cervical pregnancy and 7-week amenorrhea was admitted to the hospital after unsuccessful use of emergency contraception. Transvaginal ultrasound showed gestational sack located 11 mm from the external cervical os. Crown-rump length was 11.2 cm, and the fetal heartbeat was present. The level of serum chorionic gonadotropin was 31 930 U/L. Treatment with systemic methotrexate was unsuccessful, and unilateral uterine artery embolization was performed followed by dilatation and curettage of the cervical canal. Three days after the procedure, sonographic examination showed contracted cervical canal. After a period of two months, normal uterine artery flow was registered by Doppler ultrasonography on both sides. Conclusion. Uterine artery embolization in case of cervical pregnancy reduces the risk of bleeding and can be the method of choice when treatment with methotrexate fails. Unilateral embolization is effective when angiography shows unequal disposition of the arterial connections supplying the embryo.

scholarly journals Uterine Artery Embolization Versus Hysterectomy in the Treatment of Symptomatic Adenomyosis: Protocol for the Randomized QUESTA Trial (Preprint)

2017 ◽  
Author(s):  
Annefleur Machteld de Bruijn ◽  
Paul NM Lohle ◽  
Judith AF Huirne ◽  
Jolanda de Vries ◽  
Moniek Twisk ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Uterine Artery Embolization ◽  
Uterine Artery ◽  
Transvaginal Ultrasound ◽  
Uterine Disease ◽  
Artery Embolization ◽  
Randomized Controlled ◽  
The Impact

BACKGROUND Adenomyosis is a benign uterine disease characterized by invasion of endometrium into the myometrium resulting in heavy menstrual bleeding and pain (dysmenorrhea). Hysterectomy is established as the final treatment option when conservative treatment fails. Uterine artery embolization (UAE) in patients with symptomatic adenomyosis has demonstrated to reduce symptoms and improve quality of life. However, randomized controlled trials are lacking. OBJECTIVE With this study, we aim to evaluate the impact of UAE on Health-Related Quality of Life (HRQOL) in a randomized comparison to hysterectomy in patients with symptomatic adenomyosis. METHODS This is a multicenter non-blinded randomized controlled trial comparing UAE and hysterectomy. Eligible patients are symptomatic premenopausal women without the desire to conceive and who have symptomatic magnetic resonance imaging (MRI)–confirmed pure adenomyosis or dominant adenomyosis accompanied by fibroids. After obtaining informed consent, patients will be randomly allocated to treatment in a 2:1 UAE versus hysterectomy ratio. The primary objective is HRQOL at 6 months following the assigned intervention. Secondary outcomes are technical results, pain management, clinical outcomes, HRQOL, and cost effectiveness during 2 years of follow-up. In addition, transvaginal ultrasound (TVUS) and MRI will be performed at regular intervals after UAE. RESULTS Patient enrollment started November 2015. The follow-up period will be completed two years after inclusion of the last patient. At the time of submission of this article, data cleaning and analyses have not yet started. CONCLUSIONS This trial will provide insight for caretakers and future patients about the effect of UAE compared to the gold standard hysterectomy in the treatment of symptomatic adenomyosis and is therefore expected to improve patients’ wellbeing and quality of life. CLINICALTRIAL Netherlands Trial Register NTR5615; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5615 (Archived by WebCite at http://www.webcitation.org/6xZRyXeIF)

scholarly journals Successful Management of Cervical Ectopic Pregnancy with Bilateral Uterine Artery Embolization and Methotrexate

2018 ◽  
Vol 2018 ◽  
pp. 1-4 ◽  
Author(s):  
Keitaroh Takeda ◽  
John Mackay ◽  
Susan Watts
Keyword(s):  
Ectopic Pregnancy ◽  
Uterine Artery Embolization ◽  
Vaginal Bleeding ◽  
Uterine Artery ◽  
Transvaginal Ultrasound ◽  
Artery Embolization ◽  
Novel Approach ◽  
Beta Hcg ◽  
History Of ◽  
Cervical Ectopic Pregnancy

Cervical ectopic pregnancy (CEP) is a rare form of ectopic pregnancy. Cases diagnosed early in pregnancy can be managed medically, but more advanced pregnancies often require hysterectomy. Uterine artery embolization (UAE) is a novel approach to CEP for those who wish to preserve fertility. Here we present the case of a 44-year-old female with a 2-week history of vaginal bleeding and abdominal pain who was diagnosed with CEP and successfully treated with bilateral UAE (BUAE) in combination with methotrexate. A 44-year-old female presented to the emergency department with a 2-week history of vaginal bleeding. Serum beta-hCG was 71,964 mIU/ml. The transvaginal ultrasound confirmed CEP. The patient was referred to obstetrics and interventional radiology and ultimately treated with BUAE and methotrexate. Symptoms resolved quickly and she was discharged after 3 days.

Sign in / Sign up

Export Citation Format

Share Document